SkinHealth Systems Inc.SKIN

NasdaqHealthcareSurgical & Medical Instruments & Apparatus

Price (close)

$0.66

Market cap

$85.9M

P/E

—

Revenue (TTM)

$290.0M

Net income

-$28.4M

Dividend yield

—

1-year total return

-66.0%

Net margin

-9.8%

Revenue growth

-6.5%

Debt / equity

6.54x

What SkinHealth Systems Inc. does.

The Beauty Health Company (the “Company” or “we”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus microneedling and HydraScalp powered by Keravive, the Company combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide.

Hydrafacial is a pioneer and created the category of hydradermabrasion with its patented delivery system (“Delivery System”) that cleanses, extracts, and hydrates the skin with proprietary solutions and serums.

The treatment extends to the scalp through the Company’s HydraScalp powered by Keravive treatment, which is designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles for a visibly improved appearance of healthier, thicker, fuller-looking hair.

Revenue and profit, by fiscal year.

Fiscal year	2020	2021	2022	2023	2024	2025
Revenue	$119.1M	$260.1M	$365.9M	$398.0M	$334.3M	$300.8M
Net income	-$29.2M	-$378.8M	$44.2M	-$100.1M	-$29.1M	-$9.5M
Free cash flow	-$15.9M	-$39.6M	-$117.4M	$17.9M	$15.4M	$37.2M

More on SKIN.

Figures from SkinHealth Systems Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.